MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Revenue	3,222	3,102	2,715	2,469	2,245
Revenue Growth	15.65%	14.25%	9.96%	9.98%	-
Cost of Revenue	1,389	1,332	1,187	1,031	929
Gross Profit	1,833	1,770	1,528	1,438	1,316
Selling, General & Admin	1,212	1,183	1,080	1,051	960
Research & Development	438	448	436	437	429
Other Operating Expenses	55	17	-21	3	-12
Operating Expenses	1,705	1,648	1,495	1,491	1,377
Operating Income	128	122	33	-53	-61
Other Non Operating Income (Expenses)	-	1	-1	-1	-6
EBT Excluding Unusual Items	128	123	32	-54	-67
Merger & Restructuring Charges	-137	-137	-13	-15	-8
Legal Settlements	-6	-18	-165	-	-
Other Unusual Items	-157	-157	-	-	-
Pretax Income	-172	-189	-146	-69	-75
Income Tax Expense	129	128	52	38	16
Earnings From Continuing Operations	-301	-317	-198	-107	-91
Minority Interest in Earnings	-13	-16	-15	-5	-5
Net Income	-314	-333	-213	-112	-96
Net Income to Common	-314	-333	-213	-112	-96
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	264	257	253	253	-
Shares Outstanding (Diluted)	264	257	253	253	-
Shares Change	4.29%	1.50%	-	-	-
EPS (Basic)	-1.19	-1.30	-0.84	-0.44	-
EPS (Diluted)	-1.19	-1.30	-0.84	-0.44	-
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Free Cash Flow	-316	-420	-53	-107	-173
Free Cash Flow Per Share	-1.20	-1.64	-0.21	-0.42	-
Gross Margin	56.89%	57.06%	56.28%	58.24%	58.62%
Operating Margin	3.97%	3.93%	1.21%	-2.15%	-2.72%
Profit Margin	-9.74%	-10.73%	-7.85%	-4.54%	-4.28%
Free Cash Flow Margin	-9.81%	-13.54%	-1.95%	-4.33%	-7.71%
EBITDA	286	278	176	76	54
EBITDA Margin	8.88%	8.96%	6.48%	3.08%	2.40%
D&A For EBITDA	158	156	143	129	115
EBIT	128	122	33	-53	-61
EBIT Margin	3.97%	3.93%	1.21%	-2.15%	-2.72%

SEC Filings: 10-K · 10-Q